Logo image
Se connecter
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Article de revue   Avec comité de lecture

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis, Borja Cosio, Njira Lugogo, Arjun Mohan, Annie Burden, Lawrence Mcdermott, …
The lancet respiratory medicine, Vol.9(3), pp.260-274
03/2021

Résumé

Life Sciences

Indicateurs

1 Consultations de la notice

Détails

Logo image